Pegylated Mechano Growth Factor — Modified IGF-1 for Muscle Repair
PEG-MGF (Pegylated Mechano Growth Factor) is a pegylated variant of the MGF splice of IGF-1. The PEG modification extends its half-life, allowing systemic distribution for muscle damage repair and satellite cell activation. It is considered an experimental growth factor peptide.
Activates muscle satellite (stem) cells at sites of mechanical damage, promoting muscle fiber repair and new cell fusion. The pegylation extends circulating half-life compared to native MGF, enabling systemic rather than purely local effects.
| Parameter | Details |
|---|---|
| Starting Dose | 100 mcg 2–3x/week |
| Moderate Dose | 200 mcg 2–3x/week |
| High Dose | 300 mcg 2–3x/week |
| Route | Subcutaneous injection |
| Cycle Length | 4–6 weeks |
| Recovery Effects | 1–2 weeks |
Experimental Compound
PEG-MGF has limited human research. Most data is derived from preclinical models. Prescriber oversight and conservative dosing are essential.
This guide is for educational and clinical-support purposes only. All dosing must be supervised by a licensed prescriber. Matrix Advanced Solutions does not provide medical advice. Always consult your healthcare provider before starting any peptide protocol.